Samil Pharm (000520) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.016x

Based on the latest financial reports, Samil Pharm (000520) has a cash flow conversion efficiency ratio of 0.016x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.44 Billion ≈ $1.66 Million USD) by net assets (₩149.26 Billion ≈ $101.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000520 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Samil Pharm - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Samil Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Samil Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Samil Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Leofoo Development Co Ltd TW:2705	0.047x
Frontier Energy Ltd AU:FHE	-0.015x
Axis Corporation TWO:6292	0.190x
Wise plc LSE:WISE	0.276x
Yirendai Ltd NYSE:YRD	-0.001x
Topower Co Ltd TWO:3226	0.017x
Fima Corporation Bhd KLSE:3107	0.110x
Kencana Agri Limited F:KEBA	0.269x

Annual Cash Flow Conversion Efficiency for Samil Pharm (2012–2024)

The table below shows the annual cash flow conversion efficiency of Samil Pharm from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 000520 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩176.12 Billion ≈ $119.36 Million	₩2.59 Billion ≈ $1.76 Million	0.015x	-84.00%
2023-12-31	₩127.83 Billion ≈ $86.63 Million	₩11.75 Billion ≈ $7.96 Million	0.092x	+178.32%
2022-12-31	₩125.82 Billion ≈ $85.27 Million	₩4.15 Billion ≈ $2.82 Million	0.033x	+53.20%
2021-12-31	₩65.75 Billion ≈ $44.56 Million	₩1.42 Billion ≈ $960.19K	0.022x	-82.38%
2020-12-31	₩63.55 Billion ≈ $43.07 Million	₩7.77 Billion ≈ $5.27 Million	0.122x	-28.06%
2019-12-31	₩62.27 Billion ≈ $42.20 Million	₩10.59 Billion ≈ $7.18 Million	0.170x	+463.81%
2018-12-31	₩56.08 Billion ≈ $38.01 Million	₩-2.62 Billion ≈ $-1.78 Million	-0.047x	-163.08%
2017-12-31	₩51.17 Billion ≈ $34.68 Million	₩3.79 Billion ≈ $2.57 Million	0.074x	-30.47%
2016-12-31	₩52.87 Billion ≈ $35.83 Million	₩5.63 Billion ≈ $3.82 Million	0.107x	+98.58%
2015-12-31	₩54.41 Billion ≈ $36.87 Million	₩2.92 Billion ≈ $1.98 Million	0.054x	+124.94%
2014-12-31	₩55.42 Billion ≈ $37.55 Million	₩-11.92 Billion ≈ $-8.08 Million	-0.215x	-277.61%
2013-12-31	₩70.03 Billion ≈ $47.46 Million	₩-3.99 Billion ≈ $-2.70 Million	-0.057x	-171.32%
2012-12-31	₩62.87 Billion ≈ $42.61 Million	₩5.02 Billion ≈ $3.40 Million	0.080x	--

About Samil Pharm

KO:000520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$99.41 Million

₩146.70 Billion KRW

Market Cap Rank

#19265 Global

#933 in Korea

Share Price

₩6910.00

Change (1 day)

-1.99%

52-Week Range

₩6760.00 - ₩12310.00

All Time High

₩23603.13